PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Next-generation CAR T cells could expand solid cancer treatment options

Using cell cultures and animal models, researchers from the USC Norris Comprehensive Cancer Center at Keck School of Medicine of USC showed that innovative ways to further engineer CAR T cells can safely and effectively shrink solid tumors.

2025-10-01
(Press-News.org)

Chimeric antigen receptor (CAR) T cell therapy, which uses a patient’s own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and other blood cancers. But researchers have struggled to adapt the treatment for solid tumors—including prostate, breast, lung and ovarian cancer—which make up about 90% of all cancer cases.

Now, a research team from the USC Norris Comprehensive Cancer Center, in collaboration with City of Hope, a national cancer research and treatment organization, has found a promising solution. The researchers engineered CAR T cells to produce a fusion of two proteins: interleukin 12 (IL-12) cytokine, which boosts immune activity, and a programmed death-ligand 1 (PD-L1) blocker, an immune checkpoint inhibitor that prevents cancer cells from turning off the immune attack. In mouse models of prostate and ovarian cancer, the modified CAR T cells launched a localized attack, shrinking the tumor without causing toxicity in other parts of the body. The results were just published in the journal Nature Biomedical Engineering.

“By designing CAR T cells that release both IL-12 and a PD-L1 blocker as a fusion protein, we can make the treatment safe and also much more effective, even against tumors that usually resist CAR T cell therapy,” said the study’s senior author, Saul Priceman, PhD, associate professor in the Department of Medicine at the Keck School of Medicine of USC and founding director of the Keck School of Medicine/Norris Center for Cancer Cellular Immunotherapy Research.

The present study, which was jointly funded by the Prostate Cancer Foundation, the Department of Defense and the National Institutes of Health, focused on ovarian and prostate cancer. But researchers say the findings could be broadly applicable to other solid tumors, including gastrointestinal and brain cancers.

“We believe this new strategy will provide a productive boost to current CAR T cell therapies and can be applicable to multiple cancer types,” said John P. Murad, PhD, assistant professor of research in the Department of Medicine at the Keck School of Medicine and the study’s first author.

A localized attack

CAR T cell therapy involves altering the genes in a patient’s T cells, a type of “fighter” cell in the immune system, to make them destroy cancer. But solid cancers present a challenge, because the area within and around the tumor is hostile toward T cells, preventing them from mounting a strong attack.

Researchers have long eyed IL-12, a powerful cytokine that can reactivate T cells and favorably alter the tumor environment, as a potential solution. But delivering IL-12 on its own can cause dangerous toxicity elsewhere in the body. To work around this, the USC-City of Hope team found a clever way to increase IL-12, but only in the region near the tumor.

To keep IL-12 focused on the tumor and avoid harmful side effects elsewhere, the researchers engineered CAR T cells to localize IL-12 to solid tumors by attaching it to a PD-L1 blocker, a type of immune checkpoint inhibitor. Many cancers evade the immune system by activating “checkpoints,” signals that tell T cells to slow down or stop attacking. PD-L1 is one such checkpoint, and tumors often increase PD-L1 naturally or when they detect activated CAR T cells.

When tumors raise PD-L1 levels, PD-L1 blockers naturally gather in the area. By linking IL-12 to a PD-L1 blocker, the researchers ensured that IL-12 was delivered directly to the tumor site, boosting the immune response there while minimizing side effects in other parts of the body, where PD-L1 levels remained low.

The researchers tested the modified CAR T cells in cell cultures and mouse models, finding them to be highly effective in shrinking ovarian and prostate tumors. The approach enhanced the ability of T cells to penetrate tumors and made the surrounding environment less hostile. It was also safe, with minimal toxicity elsewhere in the body, making it an attractive therapy to translate to patients.

Broad applicability

Beyond ovarian and prostate cancers, the findings may be relevant to a range of solid cancers. The research team is now testing the approach in pancreatic cancer and plans to expand soon to colorectal and brain tumors.

“No two cancers are the same, so each needs to be tested and validated as a potential clinical approach. But the new therapy could have broad applicability, because most solid tumors create a surrounding environment that weakens the immune system, which we are capitalizing on with this strategy,” said Priceman, who also holds the Norman and Mary Pattiz Endowed Chair in Cancer Research at the Keck School of Medicine.

The researchers aim to move the technique into clinical trials within the one to two years.

The approach may also prove useful beyond CAR T cells, potentially helping to engineer other immune effector cells—the immune system’s “fighter” cells that directly attack cancer—including tumor-infiltrating lymphocytes and T-cell receptor T cells.

About this research

In addition to Priceman and Murad, the study’s other authors are Reginaldo Rosa, Yuwei Ren, Alyssa J. Buckley, Lupita S. Lopez, Yukiko Yamaguchi, Lauren N. Adkins and Catalina Martinez from the Department of Medicine and the Keck School of Medicine/Norris Center for Cancer Cellular Immunotherapy Research, Keck School of Medicine of USC, University of Southern California; Lea Christian, Anthony K. Park, Jason Yang, Candi Trac, Wen-Chung Chang and Stephen J. Forman from the Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California; Eric Hee Jun Lee from the Georgia Tech College of Engineering and Emory School of Medicine, Atlanta, Georgia; Carl H. June from the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Jun Ishihara from Imperial College London, London, United Kingdom; John K. Lee from the Department of Medicine, David Geffen School of Medicine, University of Southern California, Los Angeles; and Lawrence A. Stern from the University of South Florida, Tampa, Florida.

This work was supported by a Prostate Cancer Foundation Tactical Award [2022TACT3835]; the Department of Defense [W81XWH-21-1-0354]; and the National Cancer Institute of the National Institutes of Health [P30CA014089, P30CA033572].

END



ELSE PRESS RELEASES FROM THIS DATE:

Fungi set the stage for life on land hundreds of millions of years earlier than thought

2025-10-01
New research published in Nature Ecology & Evolution sheds light on the timelines and pathways of evolution of fungi, finding evidence of their influence on ancient terrestrial ecosystems. The study, led by researchers from the Okinawa Institute of Science and Technology (OIST) and collaborators, indicates the diversification of fungi hundreds of millions of years before the emergence of land plants. The five paths to a complex world Professor Gergely J. Szöllősi, author on this study and head of the Model-Based Evolutionary ...

DNA evidence closes gaps in global conservation databases for Amazon wildlife

2025-10-01
PHOTOS: https://sandiegozoo.box.com/s/h8ne3q1md09rpor6ewp7070qvzv9k7nh SAN DIEGO (Oct. 1, 2025) – Recent studies led by an international consortium of researchers, including scientists from the San Diego Zoo Wildlife Alliance and the Museo de Historia Natural de la Universidad Nacional Mayor de San Marcos, unveiled groundbreaking findings in biodiversity conservation through in situ DNA barcoding in the Peruvian Amazon.  Measuring the earth’s biological richness in one of its most remote and biodiverse regions is no small task. The Peruvian Amazon is in imminent danger of losing species to wildfires and habitat ...

New software tool aims to help scientists better analyze complex spatial data from tissues

2025-10-01
New York, NY [October 1, 2025]—Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University Chobanian & Avedisian School of Medicine, have developed a software platform to help scientists more easily analyze the molecular structure of tissue in both healthy and disease states. Details on the platform, called Giotto Suite, were reported in the October 1 online issue of Nature Methods [DOI: 10.1038/s41592-025-02817-w]. In recent years, new technologies have made it possible to capture detailed maps of RNA and proteins within intact tissues—a field known as spatial omics. These ...

And Swiss glaciers continue to melt

2025-10-01
Even the United Nations International Year of Glaciers' Preservation has seen further massive melting of glaciers in Switzerland. A winter with little snow was followed by heat waves in June 2025 that saw glaciers nearing the record levels of losses of 2022. Snow reserves from the winter were already depleted in the first half of July, and the ice masses began to melt earlier than had rarely ever been recorded. The cool weather in July provided some relief and prevented an even worse outcome. Nevertheless, almost a further three per cent of the ice volume was lost across Switzerland this year, ...

Scientists discover a key role of protons and superoxide ions in the respiratory chain

2025-10-01
Researchers from the Institute for Bioengineering of Catalonia (IBEC) and CIBER-BBN, in collaboration with teams from the University of Barcelona (UB) and the Institute of Chemical Research – cicCartuja, University of Seville-CSIC, have discovered that long-distance charge transport between two key proteins in the mitochondrial respiratory chain — cytochrome c and respiratory complex III — is mediated by protons and superoxide ions, which are reactive oxygen species. The study was recently published in the journal Small ...

Rare fossil reveals ancient leeches weren’t bloodsuckers

2025-10-01
A newly described fossil reveals that leeches are at least 200 million years older than scientists previously thought, and that their earliest ancestors may have feasted not on blood, but on smaller marine creatures.  “This is the only body fossil we’ve ever found of this entire group,” said Karma Nanglu, a paleontologist with the University of California, Riverside. He collaborated with researchers from the University of Toronto, University of São Paulo, and Ohio State University on a paper describing the fossil, which is now published in PeerJ. Roughly ...

Study links shift work to higher risk of kidney stones, influenced by lifestyle factors

2025-10-01
Rochester, MN, October 1, 2025 – A study evaluating how various shift work patterns contribute to kidney stone risk has revealed that shift workers have a 15% higher risk of developing kidney stones, especially younger workers and those with low levels of manual labor. Body mass index (BMI), fluid intake, and other lifestyle factors play key roles contributing to the occurrence of kidney stones. The findings of the novel study in Mayo Clinic Proceedings, published by Elsevier, indicate that kidney stone prevention efforts should extend to shift workers. Long-term shift work, identified ...

Stronger together: Community involvement is key for new transport adoption

2025-10-01
Demand-responsive transport (DRT) is promoted as an inclusive solution to first- and last-mile mobility challenges, but little is known about the barriers to adoption among people with poor health. Dr. Haruka Kato, a junior associate professor at Osaka Metropolitan University, examined the factors shaping this population's acceptance and use of DRT in Senboku New Town, Osaka. The study applied the Unified Theory of Acceptance and Use of Technology-3 (UTAUT-3) to assess the opportunities and challenges for using DRT. The findings reveal that community involvement is a powerful driver of acceptance. The study showed that residents' ...

Scientific evidence that pianists can change timbre through touch

2025-10-01
A research group led by Dr. Shinichi Furuya of the NeuroPiano Institute and Sony Computer Science Laboratories, Inc. announced research findings that for the first time scientifically clarified how pianists’ manipulations of keys alters piano timbre. Creativity in painting, music, and other arts is underpinned by the ability to create diverse perceptual experiences for audiences. However, whether timbre could actually be changed mid-instrumental performance, and what physical motor skills would be required to do so, remained unclear. The research group developed a unique sensor system that can measure piano key movements at ...

A polygenic risk score may predict future breast cancer in patients with early-stage diagnoses

2025-10-01
Bottom Line: In a retrospective study, the 313-SNP breast cancer polygenic risk score (PRS313) blood test could predict future incidents of breast cancer in women diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS). Journal in Which the Study was Published: Cancer Epidemiology, Biomarker & Prevention, a journal of the American Association for Cancer Research (AACR) Author: Jasmine Timbres, clinical information analyst at King’s College London and the study’s lead author, and Elinor J. Sawyer, PhD, the study’s senior author and professor of clinical oncology at King’s College London in the United Kingdom. Background: ...

LAST 30 PRESS RELEASES:

A step toward diagnosing the flu with your tongue

Pathogenic yeast strains found in urban air but not along the coast

NYU Grossman School of Medicine leader to receive the 2025 Research Achievement Award

New AI tool detects hidden warning signs of disease

Astrocyte-endothelial cell interaction in the aging brain

When Washington tried to starve industries of loans—and failed

Cassini proves complex chemistry in Enceladus ocean

Parkinson’s ‘trigger’ directly observed in human brain tissue for the first time

Next-generation CAR T cells could expand solid cancer treatment options

Fungi set the stage for life on land hundreds of millions of years earlier than thought

DNA evidence closes gaps in global conservation databases for Amazon wildlife

New software tool aims to help scientists better analyze complex spatial data from tissues

And Swiss glaciers continue to melt

Scientists discover a key role of protons and superoxide ions in the respiratory chain

Rare fossil reveals ancient leeches weren’t bloodsuckers

Study links shift work to higher risk of kidney stones, influenced by lifestyle factors

Stronger together: Community involvement is key for new transport adoption

Scientific evidence that pianists can change timbre through touch

A polygenic risk score may predict future breast cancer in patients with early-stage diagnoses

Genetic test can predict who could develop invasive breast cancer

Uncovering the molecular basis of long COVID brain fog

Poor sleep may accelerate brain ageing

The Lancet Infectious Diseases: New study suggests risk of long COVID in children may be twice as high after a second infection

Risk of long COVID in kids doubles after second infection

Patient-reported outcome analysis of NRG Oncology trial in limited-stage small cell lung cancer suggests quality of life benefit with twice - (vs once -) daily radiation

NRG Oncology trial analysis shows improvement in survival outcomes for glioblastoma patients receiving proton therapy, trial moves to phase III

In a landmark move, ECMWF is poised to announce a new phase in its data sharing strategy

Seal’s sensitive whiskers hold key to foiling fish escapes

Neurological outcomes after patients suffer cardiac arrest at home are similar between low- and high-income areas in Vienna

Precision without incision: the new era of functional radiosurgery

[Press-News.org] Next-generation CAR T cells could expand solid cancer treatment options
Using cell cultures and animal models, researchers from the USC Norris Comprehensive Cancer Center at Keck School of Medicine of USC showed that innovative ways to further engineer CAR T cells can safely and effectively shrink solid tumors.